METHYLPHENIDATE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 8 adverse event reports in the FDA FAERS database where METHYLPHENIDATE was used for Psoriasis.
Most Reported Side Effects for METHYLPHENIDATE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 4,924 | 15.9% | 10 | 265 |
| Off label use | 4,842 | 15.6% | 52 | 274 |
| No adverse event | 4,197 | 13.5% | 0 | 12 |
| Product quality issue | 1,728 | 5.6% | 0 | 11 |
| Disturbance in attention | 1,414 | 4.6% | 1 | 55 |
| Product substitution issue | 1,408 | 4.5% | 3 | 29 |
| Anxiety | 1,356 | 4.4% | 3 | 183 |
| Drug dose omission | 1,330 | 4.3% | 0 | 20 |
| Headache | 1,255 | 4.1% | 4 | 214 |
| Wrong technique in product usage process | 1,250 | 4.0% | 3 | 20 |
| Decreased appetite | 1,069 | 3.5% | 5 | 105 |
| Insomnia | 1,033 | 3.3% | 3 | 197 |
| Aggression | 1,003 | 3.2% | 5 | 154 |
| Toxicity to various agents | 913 | 2.9% | 352 | 578 |
| Fatigue | 858 | 2.8% | 12 | 152 |
Other Indications for METHYLPHENIDATE
Product used for unknown indication (11,355)
Attention deficit/hyperactivity disorder (9,093)
Attention deficit hyperactivity disorder (5,500)
Narcolepsy (413)
Autism spectrum disorder (316)
Disturbance in attention (300)
Depression (213)
Psychomotor hyperactivity (157)
Fatigue (124)
Anxiety (89)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)